Pancreatic cancer growth promoted by bone marrow mesenchymal stromal cell–derived IL-6 is reversed predominantly by IL-6 blockade
Pancreatic cancer is a highly lethal cancer characterized by local invasiveness, early metastasis, recurrence and high resistance to current therapies. Extensive stroma or desmoplasia is a key histological feature of the disease, and interactions between cancer and stromal cells are critical for pan...
Main Authors: | Antoon, R. (Author), Hedley, D.W (Author), Keating, A. (Author), Saleh, A.H (Author), Wang, X.-H (Author), Warrington, J. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier B.V.
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Interleukin-6/interleukin-6 receptor complex promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells
by: Zhongyu Xie, et al.
Published: (2018-01-01) -
The Immune Landscape of Osteosarcoma: Implications for Prognosis and Treatment Response
by: Caterina Cascini, et al.
Published: (2021-07-01) -
Anti-Tumor Effects of Exosomes Derived from Drug-Incubated Permanently Growing Human MSC
by: Catharina Melzer, et al.
Published: (2020-10-01) -
Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment
by: Hass Ralf, et al.
Published: (2012-09-01) -
Small Extracellular Vesicles Released from Ovarian Cancer Spheroids in Response to Cisplatin Promote the Pro-Tumorigenic Activity of Mesenchymal Stem Cells
by: Nelly Vera, et al.
Published: (2019-10-01)